AFP is a progenitor cell marker that has been considered useful in the early screening and assisting diagnosis of HCC and as a biomarker helping select candidates in testing drugs in Phase III trials or evaluating curative effects (35, 36). Here, AFP is linked to hepatocellular carcinoma.